ZAS Onco & MOSB Host Scientific Seminar on Recent Advances in Bevacizumab Therapy
ZAS Onco, a division of ZAS Corporation Ltd., in collaboration with the Medical Oncology Society of Bangladesh (MOSB), recently organized […]
ZAS Onco, a division of ZAS Corporation Ltd., in collaboration with the Medical Oncology Society of Bangladesh (MOSB), recently organized […]